Dates: April 11, 2014
Location: Hotel Monaco - 225 N. Wabash, Chicago, IL
Sponsoring Group: Cancer and Careers
Web Page URL: http://www.cancerandcareers.org/en/community/events/2014-midwest-conference
Objectives: This free conference will discuss the complexities of balancing cancer treatment and recovery with employment. Topics will include: Legal Issues Health Insurance Working During Treatment Job Re-entry Job Search.
Who Should Attend: Patients, Survivors, Oncology Healthcare Professionals
Registration Information: http://www.cancerandcareers.org/en/community/events/midwest-conference/registration
Continuing Education: Yes
Jan 12, 2012 - Ganetespib has anticancer activity in KRAS-mutant non-small-cell lung cancer (NSCLC) cells, and works synergistically with other clinical agents to increase cell death; and sorafenib also has clinical activity in patients with KRAS-mutant NSCLC, according to two studies presented at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: Biology, Therapy, and Personalized Medicine, held from Jan. 8 to 11 in San Diego.
Jan 12, 2012
May 31, 2012
Sep 3, 2014